Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.425    0.00 (0.00%)
Bid:
1.35
Ask:
1.50
Spread: 0.15 (11.111%)
Market Cap: £12.28m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

PrimaryBid.com Offer

24 Apr 2020 11:00

RNS Number : 8052K
Xeros Technology Group plc
24 April 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF XEROS TECHNOLOGY GROUP PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

 

 

 

 

Xeros Technology Group plc 

("Xeros" or the "Company")

PrimaryBid.com Offer

 

Xeros Technology Group plc (AIM: XSG), the developer and provider of water saving and filtration technologies with multiple commercial and domestic applications, is pleased to announce that following the completion of a placing of 1,140,000,000 new Ordinary Shares at 0.5 pence per share as announced at 11.00am on 24 April 2020 (the "Placing"), there is an opportunity for retail investors to participate in this fundraising through a further dedicated issue of up to 60,000,000 new Ordinary Shares at a fixed issue price of 0.5 pence per new Ordinary Share (the "Issue Price") via PrimaryBid being a discount of 33.42 per cent to the closing mid-price on 23 April 2020 (the "PrimaryBid Offer").

The PrimaryBid Offer and the Placing are conditional, inter alia, on the passing of the resolutions at the general meeting and also on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer and the Placing being admitted to trading on AIM ("Admission"). Admission is expected to be take place at 8.00 a.m. on 14 May 2020. The PrimaryBid Offer will not be completed without the Placing also being completed.

The Company will use the funds raised for the Company's current portfolio of contracts and development agreements with EBITDA cash break-even expected Q2 2022.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors from 11.01a.m. on 24 April 2020 to 3.30 p.m. on 24 April 2020. The PrimaryBid Offer may close early if it is oversubscribed.

Subscriptions under the PrimaryBid Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com).

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for new Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or call PrimaryBid.com on +44 20 3026 4750. 

The new Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing ordinary shares.

Xeros Technology Group plc

Mark Nichols, CEO

Paul Denney, CFO

www.xerostech.com 

0114 321 6328

PrimaryBid Limited

Kieran D'Silva / James Deal

 

+44 (0) 20 3026 4750

finnCap

Julian Blunt, Teddy Whiley (Corporate Finance)

Andrew Burdis, Sunila de Silva (ECM)

www.finncap.com

+44 (0) 20 7220 0500

 

 

Details of the PrimaryBid Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the PrimaryBid Offer. The Company is therefore making the PrimaryBid Offer available exclusively through PrimaryBid.com.

The PrimaryBid Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The PrimaryBid Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

The PrimaryBid Offer is open to existing shareholders and other individual investors subscribing via PrimaryBid.com. There is a minimum subscription of £100 per investor under the terms of the PrimaryBid Offer and the allocation will be filled on a "first come first served" basis.

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion.

For further details please refer to www.PrimaryBid.com. The terms and conditions on which the PrimaryBid Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

It should be noted that a subscription for new Ordinary Shares and investment in the Company carries a number of risks. Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice. Investors should take independent advice from a person experienced in advising on investment in securities such as the new Ordinary Shares if they are in any doubt. 

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEPPUQCCUPUUBC
Date   Source Headline
20th Mar 20237:00 amRNSThird Global Domestic XFilter Licensing Agreement
9th Mar 20237:00 amRNSSecond Global Domestic XFilter Licensing Agreement
1st Mar 20237:00 amRNSDirector of Finance Appointment
8th Feb 202310:23 amRNSTrading Update
9th Jan 20234:21 pmRNSBLOCK LISTING SIX MONTHLY RETURN
21st Dec 20227:00 amRNSIndia Domestic and Commercial Laundry Update
20th Dec 202212:56 pmRNSDirectorate Change
12th Dec 20227:00 amRNSDirectorate Change
10th Nov 20228:22 amRNSDirector/PDMR Transactions
3rd Nov 202210:09 amRNSHolding(s) in Company
3rd Nov 20229:54 amRNSHolding(s) in Company
1st Nov 202210:02 amRNSHolding(s) in Company
31st Oct 20225:09 pmRNSTotal Voting Rights
31st Oct 20221:47 pmRNSHolding(s) in Company
25th Oct 20225:07 pmRNSHolding(s) in Company
24th Oct 20226:02 pmRNSHolding(s) in Company
20th Oct 20225:47 pmRNSAmendment to Block Admission Application
20th Oct 20223:02 pmRNSCapital Reorganisation
20th Oct 202211:13 amRNSBlock Admission Application
20th Oct 202210:45 amRNSResults of General Meeting and Total Voting Rights
19th Oct 20221:14 pmRNSResults of Open Offer
3rd Oct 20221:06 pmRNSPosting of Circular
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
30th Sep 20223:49 pmRNSResult of Fundraise
30th Sep 202212:58 pmRNSInterim Results 2022
30th Sep 202212:51 pmRNSProposed Placing, Open Offer & General Meeting
27th Sep 20227:00 amRNSXFilter Joint Development Agreement
9th Aug 202211:51 amRNSHolding(s) in Company
26th Jul 20223:08 pmRNSResult of AGM
25th Jul 20227:00 amRNSDirectorate Change
1st Jul 202210:47 amRNSBlock Listing Six Monthly Return
30th Jun 20227:00 amRNSPublication of Annual Report and Notice of AGM
24th Jun 20229:05 amRNSSecond Price Monitoring Extn
24th Jun 20229:00 amRNSPrice Monitoring Extension
22nd Jun 20227:00 amRNS2021 Preliminary Results
14th Jun 202211:05 amRNSSecond Price Monitoring Extn
14th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20227:01 amRNSDomestic XFilter Independent Test Validation
14th Jun 20227:00 amRNSFirst Global Domestic XFilter Licensing Agreement
8th Jun 20227:00 amRNSIFB Domestic Machine Launch Update
31st Mar 20224:41 pmRNSSecond Price Monitoring Extn
31st Mar 20224:35 pmRNSPrice Monitoring Extension
31st Mar 20222:05 pmRNSSecond Price Monitoring Extn
31st Mar 20222:00 pmRNSPrice Monitoring Extension
31st Mar 202211:05 amRNSSecond Price Monitoring Extn
31st Mar 202211:00 amRNSPrice Monitoring Extension
31st Mar 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSBoard Change
8th Feb 20221:03 pmRNSDirector/PDMR Transactions, Issue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.